Recordati reported EUR428.82M in Cash and Equivalent for its fiscal quarter ending in December of 2025.





Cash And Equivalent Change Date
Almirall EUR 337.77M 14.83M Dec/2025
GlaxoSmithKline GBP 3.44B 292M Mar/2026
Hikma Pharmaceutical USD 236M 48M Jun/2025
Orion EUR 199.3M 38.4M Mar/2026
Sanofi EUR 7.66B 1.25B Dec/2025